{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T16:39:28Z","timestamp":1784651968981,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"22","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,6,4]],"date-time":"2014-06-04T00:00:00Z","timestamp":1401840000000},"content-version":"vor","delay-in-days":368,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["P30-AI027763"],"award-info":[{"award-number":["P30-AI027763"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Baylis"},{"name":"SentreHeart Inc"},{"name":"Tobira"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.jacc.2013.03.022","type":"journal-article","created":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T00:55:10Z","timestamp":1365036910000},"page":"2288-2295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":86,"title":["Atrial Fibrillation and Atrial Flutter in Human\u00a0Immunodeficiency Virus-Infected Persons"],"prefix":"10.1016","volume":"61","author":[{"given":"Jonathan C.","family":"Hsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory M.","family":"Marcus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla Y.","family":"Hsue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Scherzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Grunfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Shlipak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2013.03.022_bib1","first-page":"1","article-title":"Summary of notifiable diseases\u2014United States, 2003","volume":"52","author":"Hopkins","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jacc.2013.03.022_bib2","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0140-6736(05)67022-5","article-title":"Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study","volume":"366","author":"Sterne","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2013.03.022_bib3","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1086\/375844","article-title":"Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population","volume":"37","author":"Saves","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jacc.2013.03.022_bib4","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/0735-1097(94)90864-8","article-title":"Frequency of development of acute global left ventricular dysfunction in human immunodeficiency virus infection","volume":"24","author":"De Castro","year":"1994","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2013.03.022_bib5","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0735-1097(98)00297-6","article-title":"Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials","volume":"32","author":"Dries","year":"1998","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2013.03.022_bib6","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1161\/01.CIR.0000140263.20897.42","article-title":"Lifetime risk for development of atrial fibrillation: the Framingham Heart Study","volume":"110","author":"Lloyd-Jones","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2013.03.022_bib7","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1097\/QAD.0b013e32832d3b85","article-title":"Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study","volume":"23","author":"Grunfeld","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.jacc.2013.03.022_bib8","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/QAI.0b013e31825c7f24","article-title":"Comparison of ischemic stroke incidence in HIV-infected and non-HIV-infected patients in a US health care system","volume":"60","author":"Chow","year":"2012","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"Suppl 1","key":"10.1016\/j.jacc.2013.03.022_bib9","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/S0895-4356(01)00442-5","article-title":"The Immunology Case Registry","volume":"54","author":"Backus","year":"2001","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jacc.2013.03.022_bib10","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMsa003299","article-title":"Hospital use and survival among Veterans Affairs beneficiaries","volume":"349","author":"Ashton","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2013.03.022_bib11","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1001\/archinte.167.3.246","article-title":"Newly detected atrial fibrillation and compliance with antithrombotic guidelines","volume":"167","author":"Glazer","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2013.03.022_bib12","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/01.qai.0000371677.48743.8d","article-title":"Immunologic and virologic predictors of AIDS-related non-Hodgkin lymphoma in the highly active antiretroviral therapy era","volume":"54","author":"Engels","year":"2010","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jacc.2013.03.022_bib13","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1086\/605594","article-title":"Role of uncontrolled HIV RNA level and immunodeficiency in the occurrence of malignancy in HIV-infected patients during the combination antiretroviral therapy era: Agence Nationale de Recherche sur le Sida (ANRS) CO3 Aquitaine Cohort","volume":"49","author":"Bruyand","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jacc.2013.03.022_bib14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1478-7954-4-7","article-title":"Transition to the new race\/ethnicity data collection standards in the Department of Veterans Affairs","volume":"4","author":"Sohn","year":"2006","journal-title":"Popul Health Metr"},{"key":"10.1016\/j.jacc.2013.03.022_bib15","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2013.03.022_bib16","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1161\/CIRCULATIONAHA.109.898585","article-title":"Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons","volume":"121","author":"Choi","year":"2010","journal-title":"Circulation"},{"issue":"Suppl 2","key":"10.1016\/j.jacc.2013.03.022_bib17","doi-asserted-by":"crossref","first-page":"B10","DOI":"10.2337\/diacare.27.suppl_2.B10","article-title":"Who has diabetes? Best estimates of diabetes prevalence in the Department of Veterans Affairs based on\u00a0computerized patient data","volume":"27","author":"Miller","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2013.03.022_bib18","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1097\/01.mlr.0000228003.08925.8c","article-title":"Medical disease and alcohol use among veterans with human immunodeficiency infection: a comparison of disease measurement strategies","volume":"44","author":"Justice","year":"2006","journal-title":"Med Care"},{"key":"10.1016\/j.jacc.2013.03.022_bib19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev-med-042909-093756","article-title":"HIV infection, inflammation, immunosenescence, and aging","volume":"62","author":"Deeks","year":"2011","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jacc.2013.03.022_bib20","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1097\/QAD.0b013e3283313c91","article-title":"HIV-infected persons continue to lose kidney function despite successful antiretroviral therapy","volume":"23","author":"Choi","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.jacc.2013.03.022_bib21","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1161\/hc4901.101760","article-title":"C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation","volume":"104","author":"Chung","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2013.03.022_bib22","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1161\/01.CIR.0000103131.70301.4F","article-title":"Inflammation as a risk factor for atrial fibrillation","volume":"108","author":"Aviles","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2013.03.022_bib23","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0002-9343(99)80348-9","article-title":"The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study","volume":"98","author":"Krahn","year":"1995","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2013.03.022_bib24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ahj.2009.05.010","article-title":"Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study","volume":"158","author":"Alonso","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2013.03.022_bib25","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1001\/jama.1994.03510350050036","article-title":"Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study","volume":"271","author":"Benjamin","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2013.03.022_bib26","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/eurheartj\/ehi825","article-title":"Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study","volume":"27","author":"Heeringa","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2013.03.022_bib27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/CIRCULATIONAHA.105.595140","article-title":"Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence","volume":"114","author":"Miyasaka","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2013.03.022_bib28","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.exger.2006.12.003","article-title":"Accelerated immune senescence and HIV-1 infection","volume":"42","author":"Appay","year":"2007","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.jacc.2013.03.022_bib29","doi-asserted-by":"crossref","first-page":"e26320","DOI":"10.1371\/journal.pone.0026320","article-title":"Association of low level viremia with inflammation and mortality in HIV-infected adults","volume":"6","author":"Eastburn","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2013.03.022_bib30","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1086\/652749","article-title":"Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection","volume":"201","author":"Neuhaus","year":"2010","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jacc.2013.03.022_bib31","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ahj.2007.09.006","article-title":"Interleukin-6 and atrial fibrillation in patients with coronary artery disease: data from the Heart and Soul Study","volume":"155","author":"Marcus","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2013.03.022_bib32","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0140-6736(89)91200-2","article-title":"Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK study","volume":"1","author":"Petersen","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2013.03.022_bib33","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJM199211123272002","article-title":"Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation","volume":"327","author":"Ezekowitz","year":"1992","journal-title":"N\u00a0Engl J Med"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109713013065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109713013065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:59:04Z","timestamp":1760014744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109713013065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":33,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0735109713013065"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2013.03.022","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atrial Fibrillation and Atrial Flutter in Human\u00a0Immunodeficiency Virus-Infected Persons","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2013.03.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}